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Abstract
Acute pancreatitis is one of the most common gastro-
intestinal disorders worldwide. It requires acute hos-
pitalization, with a reported annual incidence of 13 to 
45 cases per 100000 persons. In severe cases there is 
persistent organ failure and a mortality rate of 15% to 
30%, whereas mortality of mild pancreatitis is only 0% 
to 1%. Treatment principles of necrotizing pancreatitis 
and the role of surgery are still controversial. Despite 
surgery being effective for infected pancreatic necrosis, 
it carries the risk of long-term endocrine and exocrine 
deficiency and a morbidity and mortality rate of be-
tween 10% to 40%. Considering high morbidity and 
mortality rates of operative necrosectomy, minimally in-
vasive strategies are being explored by gastrointestinal 
surgeons, radiologists, and gastroenterologists. Since 
1999, several other minimally invasive surgical, endo-
scopic, and radiologic approaches to drain and debride 
pancreatic necrosis have been described. In patients 
who do not improve after technically adequate drain-
age, necrosectomy should be performed. When mini-
mal invasive management is unsuccessful or necrosis 
has spread to locations not accessible by endoscopy, 
open abdominal surgery is recommended. Addition-
ally, surgery is recognized as a major determinant of 
outcomes for acute pancreatitis, and there is general 
agreement that patients should undergo surgery in the 
late phase of the disease. It is important to consider 
multidisciplinary management, considering the clinical 
situation and the comorbidity of the patient, as well as 
the surgeons experience.
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Core tip: The surgery and its timing are contentious 
regarding treatment of severe acute pancreatitis and 
related complications. Many studies showed that “early” 
open surgery has been accompanied often by higher 
mortality and morbidity rates, and should be the next 
step in treating severe acute pancreatitis complications, 
when minimally invasive management fails. In this re-
view article, current treatment options and results are 
discussed. 
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INTRODUCTION
Acute pancreatitis (defined as the acute nonbacterial in-
flammatory condition of  the pancreas) is derived from 
early activation of  digestive enzymes inside acinar cells, 
with varying compromising of  the gland itself, nearby tis-
sues, and other organs. It is well known that several situa-
tions develop into acute pancreatitis, but the mechanisms 
and how those mechanisms develop the disease remain 
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unclear. Why do some individuals develop edematous 
pancreatitis and others develop a more severe necrotic 
pancreatitis? Knowledge regarding pancreatitis pathogen-
esis may have important implications in prevention and 
treatment of  the disorder. If  the early events that gener-
ate the inflammatory process are understood - and if  pro- 
and anti-inflammatory factors that modulate the severity 
of  the disease are known - treatment can be implemented 
so the process will not happen or possible associated 
complications will be minimized[1].
Acute pancreatitis is one of  the most common gas-
trointestinal disorders requiring acute hospitalization 
worldwide, with a reported annual incidence of  13 to 45 
cases per 100000 persons[2]. In the United States, it is the 
third most common gastrointestinal disorder requiring 
acute hospitalization[3]. In the United States alone, acute 
pancreatitis leads to 270000 hospital admissions annually 
and in-patient costs exceeding 2.5 billion dollars[4].
It is rare in childhood but may occur at any age (ac-
cording to recent publications[5,6], median age, 55-58 yr). 
Acute biliary pancreatitis is more common in women, 
and alcoholic pancreatitis is more common in middle-
aged men[6].
Although most patients with acute pancreatitis re-
cover without sequelae, between 10% to 20% will have 
a more complicated clinical course with higher risks of  
morbidity and mortality[7]. Severe acute pancreatitis (SAP) 
requires prolonged hospitalization, frequently including 
a stay in the intensive care unit (ICU) because of  organ 
dysfunction[8].
Severe pancreatitis is associated with a mortality of  
15% to 30%, whereas mortality from mild pancreatitis is 
only 0% to 1%, and organ failure is the most important 
determinant of  mortality in acute pancreatitis. However, 
in approximately 30% of  patients with necrotizing pan-
creatitis, a secondary necrotic infection occurs, mostly 3 
to 4 wk after the onset of  necrotizing pancreatitis[9]. If  
left untreated, mortality of  infected necrosis approaches 
100%[3,10]. Initial treatment of  SAP is primarily medical, 
and these patients require intensive organ support[11,12]. 
Surgery for SAP is a morbid procedure associated with 
complications in 34% to 95% of  patients, and mortality in 
11% to 39%[13,14]. Surgery may lead to long-term pancre-
atic insufficiency[14,15]. The high mortality rate encountered 
with surgery reflects the hazards of  operating on critically 
ill septic patients, often with multiorgan failure[16].
Surgery and its timing are the focus of  contention 
when treating SAP. Decades ago, some experts used lapa-
rotomy in the early phase of  SAP to debride and drain 
the retroperitoneal infected necrosis[17,18]. However, stud-
ies have shown that “early” surgery is often accompanied 
by higher mortality[19,20], and several studies also have 
shown that there is success with some SAP patients with 
retroperitoneal infected necrosis, conservatively managed 
without high-risk surgical intervention; therefore, many 
experts advocated delayed surgery[20,21]. In recent decades, 
higher mortality rates during early surgery resulted from 
those SAP cases that underwent traditional laparotomy 
(which may cause severe trauma) to debride and drain the 
retroperitoneal infected necrosis[22]. After several studies 
showed that high mortality rates for severe necrotizing 
pancreatitis came with early surgery, the 2002 Interna-
tional Acute Pancreatitis guidelines recommended avoid-
ing surgical intervention during the first 14 d after onset, 
unless there was progressive multiple organ failure and 
clinical deterioration. Subsequent studies have suggested 
that morbidity and mortality rates can be reduced further 
if  surgery is delayed beyond 28 to 30 d[9], because the 
extended interval allows sufficient demarcation between 
normal and necrotic tissue, reducing the risk of  inciting 
overwhelming postoperative septic and systemic inflam-
matory responses, and the risk of  intraoperative injury to 
surrounding organs and hemorrhage[23].
Faced with high morbidity and mortality rates of  
operative necrosectomy, minimally invasive strategies 
are being increasingly explored by gastrointestinal sur-
geons, radiologists, and gastroenterologists[24]. As techni-
cal ability and endoscopic tools have gradually become 
more precise, the mortality rates of  patients with severe 
pancreatitis have improved, and there are fewer com-
plications compared to those having open debridement 
treatment[25]. Percutaneous catheter drainage (PCD), 
endoscopic transgastric procedures, and a minimally inva-
sive approaches all have been proposed as alternatives to 
open necrosectomy[16]. When minimal invasive manage-
ment is unsuccessful or necrosis has spread to locations 
not accessible by endoscopy, open abdominal surgery is 
recommended[25]. 
CLASSIFICATION AND SCORING
The Atlanta Classification system for acute pancreatitis 
came about as a result of  the Atlanta Symposium of  
1992, and, despite there being some confusion over defi-
nitions, it has been a practical aid for health care provid-
ers[11]. Since then, with improvements in the understand-
ing of  organ failure and necrotizing pancreatitis, and in 
diagnostic tools, some revisions have been made through 
a working group consultation with eleven international 
pancreatic societies[26]. The fourth draft, in current use, 
contains a clinical assessment of  severity and the previ-
ous confusing definitions concerning local complications 
have been further clarified. The criteria for the diagnosis 
of  acute pancreatitis, the differences between the two 
forms (i.e., interstitial edematous pancreatitis and nec-
rotizing pancreatitis), the three categories of  severity of  
acute pancreatitis (mildly acute, moderately severe acute, 
and severe acute)[27,28], and the morphology observed in 
diagnostic images of  pancreatic and peripancreatic col-
lections brought about by complications are now more 
clearly set out.
Criteria to help in classifying severity are the presence 
of  transient organ failure (that which is present for less 
than 48 h), persistent organ failure (continuing for more 
than 48 h), and local (such as, peripancreatic fluid or 
acute necrotic collections) or systemic complications (such 
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as exacerbations of  underlying comorbidities related to 
the acute pancreatitis)[29-31].
Scoring systems
Attempts to define objective criteria for assessing disease 
severity and prognosis were pioneered in the 1970s by 
Ranson et al[32] and Blamey et al[33]. The 2 scoring systems 
include basic laboratory data and clinical variables ob-
tained 48 h after hospital admission. In subsequent years, 
these scoring systems have found widespread application 
and have undergone numerous modifications. Several 
large studies have shown a close correlation between 
advanced age and nonsurvival in acute pancreatitis[34-36]. 
Advanced age often is associated with comorbidities (e.g., 
cardiovascular disease, diabetes, and overall decreased 
biological resistance)[36], and therefore, increases risk 
of  fatal outcome. Comorbidities have been included in 
multiple parameter scoring systems such as the Acute 
Physiology and Chronic Health Examination (APACHE) 
Ⅱ system, the most widely used index for early risk strati-
fication[37]. Although more recent iterations of  this scor-
ing system have been developed, the advantages of  the 
APACHE Ⅱ are its familiarity, its objective nature, and 
its ability to be calculated at any time during a patient’s 
hospital stay. Use of  the APACHE Ⅱ in clinical practice 
has several important limitations (e.g., the requirement for 
multiple parameters and an online calculator - versions of  
which are widely available on the Internet)[38]. As a result, 
several additional scoring systems have been developed 
for bedside application.
A more recent scoring system developed for use dur-
ing the first 24 h of  admission to the hospital is the Bed-
side Index of  Severity in Acute Pancreatitis[7]. This system 
was derived using data from 17992 patients and validated 
on a population of  18256 patients in the United States. 
This 5-factor scoring system has a similar accuracy as the 
APACHE Ⅱ for predicting death in the initial retrospec-
tive study and in several subsequent prospective cohort 
studies[39]. The Bedside Index of  Severity in Acute Pan-
creatitis is a simplified scoring system that can be applied 
easily in the earliest phases of  acute pancreatitis helping 
identify those patients with an increased risk of  death.
DEFINITION AND COMPLICATIONS
Defining the severity of acute pancreatitis
There are three good reasons for defining the severity 
of  acute pancreatitis: the first being diagnosing those pa-
tients who may need aggressive early treatment in cases 
of  severe acute form; the second is the identification of  
patients who may need to be transferred to a specialist 
care unit; and the third is that placing these patients into 
sub-groups according to particular complications will aid 
the specialists to whom they are transferred[26].
Mild acute pancreatitis
Patients without organ failure or complications are clas-
sified as having mild acute pancreatitis. They are usually 
discharged at an early stage, do not need pancreatic im-
aging, and death as a result of  the disease is extremely 
uncommon[40].
Moderately severe acute pancreatitis
This is diagnosed when transient organ failure, local 
complications (such as prolonged abdominal pain, leuko-
cytosis, or fever caused by peripancreatic collections, or if  
the patience can not feed normally), or systemic compli-
cations (such as when coronary artery disease or chronic 
lung disease is made worse as a result) are present. This 
form of  the disease can resolve itself  without treatment 
(when transient organ failure or acute fluid collection is 
involved) or specialist care may be needed (when exten-
sive sterile necrosis is present, but organ failure is not). 
The chance of  death as a result of  this form is lower 
than in cases of  the severe acute form[27].
Severe acute pancreatitis
This is diagnosed when there is persistent single or mul-
tiple organ failure, resulting from systemic inflammatory 
response syndrome caused by cytokine cascades at an 
early stage[30,31,41,42], which can complicate the pancreati-
tis, lead to other complications, and increase the risk of  
death (a 36% to 50% mortality rate), commonly due to 
infected necrosis, if  this is in the first few days of  the 
disease[31,41,42].
One systematic review into deaths caused by necrosis 
in the absence of  organ failure (11% of  patients) resulted 
in a four tier grading of  severity being proposed[28], while 
two large Dutch studies came up with a figure of  6%[43,44]. 
The differences in morphological characteristics of  local 
complications and their different treatments need to be 
determined to prevent mortality.
Necrotizing pancreatitis
Necrosis, which affects between 5% and 10% of  patients, 
generally involves both the pancreas and peripancreatic 
tissue, although sometimes just the peripancreatic tissue, 
and, even more rarely, only the pancreatic parenchyma.
With patients who have peripancreatic necrosis, as in 
those with interstitial edematous pancreatitis, the pan-
creas enhances normally on contrast-enhanced computed 
tomography, but morbidity is increased and intervention 
rates are higher[40,45,46]. The progression of  both pancre-
atic and peripancreatic necrosis varies, remaining solid or 
liquefying, becoming infected or remaining sterile, per-
sisting for a long time or gradually disappearing.
Infected pancreatic necrosis
Both forms of  necrosis can become infected, but the ma-
jority of  evidence shows no certain correlation between 
its extent, the risk of  infection, and its duration, although 
it is not common in the first week[9,43]. Its diagnosis is 
crucial as antibiotic and other necessary treatments need 
to be applied as soon as possible[47]. If  computed to-
mography (CT) scans show up extraluminal gas in the 
pancreas or peripancreatic tissue, or if  biopsies detect 
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Post-necrotic pancreatic/peripancreatic fluid collections 
(PNPFC): fluid collections associated with necrotizing 
pancreatitis, containing fluid and necrotic tissue, which 
over the course of  weeks, evolve into a necrotic fluid col-
lection with liquid and solid debris; and (5) WON: these 
are formed because of  encapsulation of  the PNPFC over 
time in a thickened wall of  fibrous or granulation tissue 
without an epithelial lining at the interface of  necrotic 
tissue, generally maturing after the first month of  nec-
rotizing pancreatitis. Walled-off  necrosis, resulting from 
necrotic pancreatic parenchyma and/or necrotic peripan-
creatic tissue, can be sterile or infected, and there can be 
many of  them, sometimes in locations distant from the 
pancreas[52]. Walled-off  necrosis helps to distinguish the 
necrotic tissue from the parenchyma, thereby lessening 
the chances of  bleeding and the loss of  vital tissue during 
surgery, although this can result in pancreatic exocrine 
and endocrine deficiency[53,54].
Bradley et al[55] suggested a conservative approach to 
sterile pancreatic necrosis, although the Acute Pancreati-
tis Classification Working Group found that patients may 
continue to be ill even when there was no infection[26,55]. 
Secondary infection, which usually occurs two to four 
weeks after primary infection, commonly results in sepsis, 
multi-organ failure, and patient mortality[56]. High Ranson’
s and APACHE-Ⅱ scores are good indicators of  the 
possibility of  death, and even those with severe sterile 
necrosis have a high mortality rate if  their overall health 
is not good.
Defining systemic complications
Systemic complications are classed as those arising from 
already existent complaints, such as coronary artery dis-
ease, or chronic lung disease, made worse by the acute 
pancreatitis. The Acute Pancreatitis Classification Work-
ing Group made a distinction between these and persis-
tent organ failure, the latter being the main feature of  the 
severe acute form.
TREATMENT
Management of infected pancreatic necrosis
Pancreatic necrosis surgery, the principles of  which were 
laid out by Moynihan in 1925[57], involves isolating the 
pancreas from the abdominal cavity and cellular fat spac-
es, and draining the amassed peripancreatic fluid. The 
aim is to check the sepsis and control the release of  pro-
inflammatory mediators. The combination of  debriding 
the necrotic tissue and removing retro-peritoneal debris 
and exudate is carried out in order to preserve the organ. 
Four principle surgical methods are recommended: (1) 
being necrosectomy alongside open packing[58]; (2) being 
planned, staged relaparotomies with repeated lavage[21]; 
(3) being closed continuous lavage of  the lesser sac and 
retro-peritoneum[59]; and (4) being closed packing[60]. 
These days, the third method is most often used to 
remove post-operative residual pancreatic necrosis as it 
has the lowest rate of  morbidity[24,53]. Surgery has the pos-
bacteria and/or fungi on Gram stains and cultures, then 
infection is highly likely[48]. Signs of  suppuration may also 
be evidence of  liquefaction and will increase over time. 
Despite the first version of  the Atlanta Classification de-
fining a localized collection of  purulent material without 
significant necrotic material as a pancreatic abscess, the 
term was found to be unhelpful and is not used in the 
revised version. Secondary infections have been found to 
increase the the chances of  morbidity and death[49].
Acute pancreatitis complications
Defining organ failure: Organ failure in the respira-
tory, cardiovascular, and renal systems is defined using 
the modified Marshall scoring system: a score of  two 
or more for one of  these systems is sufficient[50]. This 
system is preferred over the Sepsis-related Organ Failure 
Assessment scoring system, used in critical care units, 
as it is easier to use and gives objective results, although 
both systems could be used to help stratify the severity 
of  organ failure[51].
Defining local complications: The original Atlanta 
Classification was useful because it recognized the dif-
ferences between uncomplicated interstitial pancreatitis 
and acute pancreatitis with local complications[11]. Local 
complications (such as acute peripancreatic fluid collec-
tion, pancreatic pseudocyst, acute necrotic collection, 
walled-off  necrosis, gastric outlet dysfunction, splenic 
and portal vein thrombosis, and colonic necrosis) and 
their clinical consequences are now better understood 
and described. Signs that these problems may be present 
are persistent abdominal pain, secondary serum pancre-
atic enzyme activity increases, organ dysfunction getting 
worse, and symptoms of  sepsis (i.e., fever, white blood 
cell increases, etc.), although imaging may be necessary 
for correct diagnosis[26].
The definitions of  pancreatic fluid collections are 
based on the revised Atlanta classification by the Acute 
Pancreatitis Classification Working Group and are de-
scribed as follows: (1) Acute peripancreatic fluid collec-
tions (APFC): these are not connected to necrosis, occur 
in the first four weeks of  acute pancreatitis, are entirely 
liquid, found in or near the pancreas, and have no fibrous 
wall or granulation tissue. Those which resolve them-
selves or have no symptoms need no treatment and are 
not classed as severe acute pancreatitis; (2) Pseudocyst: 
a collection of  pancreatic juice, containing no solid ne-
crotic material, enclosed by a wall of  fibrous or granula-
tion tissue resulting from acute pancreatitis, pancreatic 
trauma, or chronic pancreatitis. They are a result of  the 
main pancreatic duct or its intrapancreatic branches be-
ing disrupted in the absence of  pancreatic parenchymal 
necrosis and causing pancreatic juice to leak persistently 
and collect, usually after the first month; (3) Infected 
pseudocyst: this contains purulent liquid with no solid ne-
crotic material (although there may be other solid debris) 
and can be diagnosed by following the patient’s clinical 
course or through the presence of  gas on CT scans; (4) 
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sibility of  saving the patient’s life, but it carries a high risk 
of  morbidity and mortality, between 4% and 10%, and 
possible long-term endocrine and exocrine deficiency[25]. 
In addition, timing of  surgery has been increasingly rec-
ognized as a major determinant of  outcome in acute pan-
creatitis, and there is general agreement that patients must 
undergo operation in the late phase of  the disease. How-
ever, the definition of  late differs between studies[53,61]. It 
has been reported that mortality from necrotizing pan-
creatitis can be reduced by avoiding surgical therapy or by 
postponing surgery until the late stage of  the disease[62].
Despite the availability of  several clinical (Ranson cri-
teria, acute physiology and chronic health evaluation Ⅱ 
score, and APACHE Ⅱ) and radiologic grading systems 
(Balthazar scoring system, modified computerized to-
mography severity index), there is no consensus on accu-
rately predicting the best treatment strategy and outcome 
after acute necrotizing pancreatitis[63-65].
The treatment principles of  necrotizing pancreati-
tis and the role of  surgery remain controversial. In the 
1990s, more than 60% of  patients with the disease were 
treated surgically[18]. In 1991, Bradley and Allen defined 
pancreatic necrosis as the principal determinant of  
survival in acute pancreatitis, but they recommended 
conservative treatment of  sterile necrosis in selected 
cases[55]. Guidelines of  the International Acute Pancreati-
tis recommend doing a fine-needle aspiration biopsy in 
patients with necrotizing pancreatitis and signs of  sepsis. 
Once fine-needle aspiration biopsy-proven infection of  
necrosis has been shown, it is considered an indication 
for surgery[53].
Recent reports have shown that a subset of  patients 
with SAP developing infected fluid collection, pancre-
atic necrosis, or pancreatic abscess can be managed by 
PCD[66]. It was hypothesized that simple drainage with 
regular-bore (12- to 14-Fr) percutaneous catheters is an 
effective therapeutic option. This recommendation is 
based on the premise that is not necessary to remove all 
necrotic tissue to successfully treat patients with infected 
pancreatic necrosis. By performing drainage of  infected 
fluid under pressure, the clinical condition might im-
prove and the necrotic tissue may successfully be dealt 
with by the patient’s immune system. The goal of  drain-
age has been to remove infected fluid rather than the 
necrosis[67]. However, PCD used for infected pancreatic 
necrosis has been criticized for its poor ability to remove 
solid debris. 
Percutaneous drainage is usually performed under 
computed tomography, whereas sonographically con-
trolled PCD rarely has been reported[68]. The success rate 
of  percutaneous catheter drainage in infected pancreatic 
necrosis varies and ranges from 0% to 78%[43,69]. van Baal 
et al[70] reported a meta-analysis, which included 384 pa-
tients from 11 studies, of  PCD as a primary treatment for 
necrotizing pancreatitis. Surgical necrosectomy could be 
avoided in 56% of  the patients and the overall mortality 
rate was 17%. However, infected necrosis was confirmed 
in only 71% of  the patients.
In a recent report, authors aimed to identify factors 
that led to surgical intervention after initial management 
with PCD, and also to identify a subgroup of  patients 
where PCD alone would be effective. Twenty-seven 
patients (38.5%) underwent surgery after initial PCD. 
Indications for surgical intervention were ongoing sepsis 
not controlled by interventional radiologic management. 
In that study, percutaneous catheter drainage achieved 
sepsis reversal in 62% of  patients and complete recovery 
was achieved without surgical intervention in 48% of  
patients[16].
Gagner first described minimally invasive surgical 
treatment of  necrotizing pancreatitis in 1996, includ-
ing laparoscopic retrocolic, retroperitoneoscopic, and 
transgastric procedures[71]. Over the past 15 years, several 
other minimally invasive surgical, endoscopic, and radio-
logic approaches for draining and debriding pancreatic 
necrosis have been described[23].
A literature search of  the MEDLINE database from 
April 1996 to November 2010 was performed for each 
of  the 4 techniques for minimally invasive necrosectomy: 
percutaneous therapy (341 studies), endoscopic necro-
sectomy (574 studies), laparoscopic necrosectomy via a 
transperitoneal approach (148 studies), and retroperito-
neal necrosectomy (194 studies). Only cohorts with at 
least 10 or more patients were included. Twenty-seven 
studies with 947 patients were examined (8 studies on 
percutaneous approach; 10 studies on endoscopic ne-
crosectomy; 2 studies on laparoscopic necrosectomy via 
a transperitoneal approach; 5 studies on retroperitoneal 
necrosectomy; and 2 studies on a combined percutaneous 
retroperitoneal approach). Finally, the authors advocated 
a multidisciplinary approach with interventional radiolo-
gists, gastroenterologists, intensivists, and hepatobiliary 
surgeons at tertiary care centers. They concluded that 
because the comparison data are limited, the minimally 
invasive approach should be based on location of  lesion 
and individual patient presentation[23].
A prospective, randomized, multicenter trial called the 
Minimally Invasive Step Up Approach Versus Maximal 
Necrosectomy in Patients with Acute Necrotizing Pan-
creatitis (PANTER) was performed in the Netherlands[43]. 
After diagnosing necrotizing pancreatitis or infected pan-
creatic necrosis, patients were randomly assigned to either 
a step-up approach or 2 open necrosectomy. The step-up 
approach consisted of  percutaneous drainage or endo-
scopic drainage, followed by a minimally invasive retro-
peritoneal necrosectomy if  necessary. A video-assisted 
retroperitoneal debridement (VARD) with postoperative 
lavage was performed 3 d after if  there was no clinical 
improvement. Major complications or death occurred in 
31 of  45 patients after open necrosectomy (69%) vs 17 of  
43 patients after the step-up approach (40%). About 35% 
of  patients in the step-up group could be managed with 
percutaneous drainage only[43].
Similar to the PANTER Trial, there also is a recent, 
prospective multicenter, single-arm study from the Uni-
versity of  Washington. Percutaneous drainage was used 
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as an initial treatment for infected pancreatic necrosis. If  
there was a 75% reduction in size based on a follow-up 
scan 10 d later, the remainder of  their treatment would be 
percutaneous drains alone. If  patients did not have a 75% 
reduction, they were treated with a VARD. Twenty-three 
percent of  patients were treated with percutaneous drains 
only. Sixty percent of  patients were treated with a mini-
mally invasive intervention (i.e., drains with or without a 
VARD). Mortality at 30 d was 2.5%. The percutaneous 
approach to infected pancreatic necrosis has been shown 
to be safe and feasible in multiple retrospective case se-
ries. It is noteworthy that 44% of  patients reviewed in the 
studies did not need surgical therapy. What has become 
increasingly popular is combined percutaneous technique 
with a VARD as mentioned in the PANTER trial and 
the Horvath study[72]. These studies not only confirmed a 
subgroup of  patients that can benefit from percutaneous 
drainage alone but also examined a combined technique 
in a prospective manner with a relatively larger amount 
of  patients.
Retroperitoneal laparoscopic debridement drainage 
(RLDD) for treating retroperitoneal infected necrosis in 
SAP has been rarely reported, and there has been no re-
port regarding comparison of  curative efficacy between 
RLDD and laparotomy. This study showed that RLDD 
(a minimally invasive procedure) has obvious advantages 
for treating SAP retroperitoneal infected necrosis. It is 
safe and effective when done early and can prevent sys-
temic inflammatory response syndrome from progress-
ing further[22].
The overall message of  these studies is that in patients 
who do not improve after adequate drainage, necrosec-
tomy should be performed next. The percutaneous drain, 
together with the computed tomography scan, can be 
used as a roadmap for (minimally invasive) necrosectomy. 
Percutaneous (or transgastric) drainage should be the first 
intervention, and the indication for drainage should be 
the same as for surgical necrosectomy[3].
Direct endoscopic necrosectomy (DEN) is a mini-
mally invasive treatment introduced recently for treating 
infected WON[73]. Using DEN, a stoma is created en-
doscopically between the enteric lumen and the walled-
off  fluid collection, allowing insertion of  an endoscope 
into the fluid collection, which allows for an endoscopic 
necrosectomy. Current data suggest that DEN is a less 
invasive and less risky alternative to open surgical necro-
sectomy for managing infected WON and infected pseu-
docyst with solid debris[74].
Two large, multicenter, retrospective studies demon-
strated that necrosis managed using direct transluminal 
endoscope techniques resulted in a positive prognosis 
and a high success rate at the beginning[75,76]. Neverthe-
less, all of  the current endoscopic techniques have inher-
ent limitations (e.g., risk of  air embolism, endoscopically 
uncontrollable bleeding, and inadequate drainage through 
multiple plastic stents) together with early occlusion of  
the fistulous tract. To overcome these difficulties, Hritz 
and associates demonstrated a successful method of  
endoscopic transluminal necrosectomy - a combination 
of  the temporary placement of  a self-expanding metal 
stent into the fistulous tract and daily irrigations of  the 
necrotic cavity with a high-flow water-jet system using a 
flush knife[77].
Percutaneous techniques, including VARD, need 
open necrosectomy in a high proportion of  patients, and 
mortality is around 20%[3]. It is now well recognized that 
most sterile collections do not require intervention (at 
least in the early phase of  disease), and that mortality and 
morbidity rates after an intervention are time dependent, 
falling to almost 0% by the stage of  a sterile WON. The 
indication for early intervention for infected necrosis 
is limited to sepsis control, and there is increasing con-
sensus within this group that some form of  minimally 
invasive approach may enhance outcomes. Conventional 
management of  late pancreatic collections was by open 
pancreatic cystgastrostomy, but with developments in in-
terventional radiology, therapeutic endoscopy, and mini-
mal access surgery, new techniques have been used as 
alternatives to this approach[78]. While all have proven to 
be feasible in small cohort series, there is little evidence 
to the relative benefits of  one method over another for 
managing APFC[79,80]. 
Laparoscopic cystgastrostomy (LCG) is used in 
mature symptomatic collections. It facilitates complete 
drainage of  the collection with a minimal requirement for 
re-intervention. It also allows simultaneous management 
of  gallstones. Laparoscopic cystgastrostomy should allow 
a wide debridement of  the cyst cavity with the advan-
tages of  a minimally invasive approach. Open cystogas-
trostomy (OCG) is used when an intervention is required 
on additional intra-abdominal pathology (e.g., enteric 
stricture or fistula) or where collection anatomy precludes 
other approaches. Laparoscopic cystgastrostomy allows 
larger collections to be managed by a one-step interven-
tion, and the solid necrosis to be more effectively drained. 
Importantly, definitive management of  gallstones can 
be achieved. However, the concept that endoscopic 
ultrasound (EUS)-guided drainage (the least invasive ap-
proach) may be of  most benefit in fluid predominant col-
lections requires evaluation within a study format, as ex-
perience has shown some APFC with significant necrosis 
may resolve completely using this approach only. Optimal 
management of  collections with intermediate (size and 
fluid content) characteristics is not clear, and there may 
be clinical equipoise regarding whether a laparoscopic 
or endoscopic cystgastrostomy should be used as the 
preferred approach. A well-conducted, randomized, con-
trolled study is required to determine which method is 
most effective in this particular group of  patients[78].
In summary, standard treatment for infected pancre-
atic necrosis is open or laparoscopic surgical drainage. 
However, on occasions, percutaneous drainage may work 
well. As recommended by the International Association 
of  Pancreatology Clinical Guideline, drainage should be 
effectively established when the patient is septic. A step-
by-step treatment is proposed by which percutaneous or 
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endoscopic drainage should be established first and then 
necrosectomy with drainage through a minimally invasive 
retroperitoneal access. When this method was compared 
with open surgery, it offered several advantages including 
the chance to avoid surgery in some patients, fewer com-
plications, and lower cost[43,53,70].
The alternatives to open surgery should be consid-
ered, mainly in frail and critical patients who would not 
tolerate more aggressive surgery. In clinical practice, it 
is important to consider the importance of  a multidis-
ciplinary management, considering the clinical situation 
and comorbidity of  the patient and the experience of  the 
personnel.
Pancreatic duct breaking: Generally this is produced 
in the context of  pancreatic necrosis because of  erosion 
of  the duct. In cases of  necrosis, complete or partial pan-
creatic duct breaking occurs in about 60% of  cases. To 
assess this situation, wirsungography by using computed 
tomography, nuclear magnetic resonance (spectroscopy), 
or endoscopic retrograde cholangiopancreatography can 
be performed. This latter method may be associated with 
placing a stent, which will favor definitive resolution. Nu-
tritional support and potent antisecretors (e.g., octreotide) 
should be associated. Collections can be removed by per-
cutaneous or endoscopic drainage. Successful fistula seal-
ing is described using cyanoacrylate or fibrin[81]. If  other 
treatments fail (which is common) surgery is indicated. 
However, in cases of  complete duct rupture, it is rarely 
successful to access the residual duct in the pancreatic 
tail. In such cases, a distal pancreatic resection may be cu-
rative. Otherwise, internal drainage through a pancreatic-
digestive anastomosis, may be necessary[1].
Pancreatic pseudocyst
According to several retrospective studies, the incidence 
of  a pseudocyst after acute pancreatitis varies depend-
ing on the definition and methods of  detecting a pseu-
docyst. The incidence ranges from 5% to 16%, and is 
reported as being higher in patients with underlying 
chronic pancreatitis[82-84].
Treatment of  pancreatic pseudocysts: Fluid collec-
tions that appear during disappear spontaneously in 40% 
to 50% of  cases. In about 10% to 15% of  cases, these 
collections persist and become encapsulated, generating 
pancreatic pseudocysts. A true pancreatic pseudocyst (i.e., 
without an epithelial lining; the counterpart would be a 
pancreatic cyst) takes at least 4 to 6 wk from the begin-
ning of  symptoms to be encapsulated by a wall formed 
by inflammatory fibrosis of  the adjacent tissues. Few 
studies have documented the natural evolution of  pan-
creatic pseudocysts. It has been thought that pancreatic 
pseudocysts more than 6 cm in diameter, or those that 
persisted for more than 6 wk, should be operated on[1] 
despite some studies showing that 50% of  those which 
had no symptoms or were smaller than 10 cm resolved 
of  their own accord[84]. It also has been shown that about 
half  of  all pancreatic pseudocysts can be solved sponta-
neously; thus, the attitude has shifted toward a more con-
servative approach.
Asymptomatic pancreatic pseudocysts may be fol-
lowed for periods of  6 mo or longer if  they do not grow, 
become symptomatic, or present complications (e.g., 
hemorrhage, infection, or mechanical compromise of  
adjacent organs). In these situations, percutaneous, en-
doscopic, or surgical drainage should be considered. It 
depends on several factors: patients’ general status, size, 
number, and location of  pseudocysts, communication (or 
not) with the main pancreatic duct, solid necrosis inside 
(or not), and possible complications[1]. 
Despite almost 50% of  pseudocysts resolving them-
selves, the remainder can become symptomatic or in-
fected, and may rupture, hemorrhage, develop vascular 
thrombosis, or obstruct nearby viscera, resulting in the 
need for some kind of  medical intervention[85,86].
A ruptured pseudocyst, if  it causes hemorrhaging in 
the digestive tract, will need immediate treatment, while 
if  it occurs in the peritoneal cavity, it can lead to perito-
nitis or hemorrhagic shock requiring emergency explor-
atory surgery[25].
Kim et al[84] report spontaneous resolution, includ-
ing disappearance and a size decrement, was achieved in 
71.6% of  cases despite the higher proportion of  underly-
ing chronic pancreatitis, and there was no significant dif-
ference in spontaneous resolution rate between acute and 
acute-on-chronic pancreatitis groups. Therefore, the wait-
and-see policy for more than 4 to 6 wk may be feasible, 
unless the pseudocysts are associated with symptoms or 
complications. Although there have been differing results 
concerning spontaneous resolution of  pseudocysts ac-
cording to the study, size, detection time, and cause of  
the underlying pancreatic disease were reported as predic-
tive factors[87-89]. The presence of  an underlying chronic 
pancreatitis, an alcoholic cause, and a long interval from 
symptom onset until admission are risk factors for a 
pseudocyst, and a single lesion is a predictor of  sponta-
neous resolution[84].
Percutaneous drainage should be avoided in cases 
of  hemorrhage or pancreatic ascites. Surgical treatment 
(mainly by internal drainage) is reserved for patients in 
whom percutaneous or endoscopic treatment has failed, 
those with complications from chronic pancreatitis, those 
with multiple or giant pseudocysts, or when malignancy 
cannot be ruled out[90,91].
Hemorrhage or pseudoaneurysm
Hemorrhagic complications: Hemorrhagic complica-
tions of  acute pancreatitis are fortunately rare; however, 
they may present in a diversity of  forms. Sometimes, 
upper or lower gastrointestinal bleeding occurs because 
of  gastroduodenitis secondary to adjacent inflammation, 
bleeding peptic ulcer, pseudocyst rupture into the diges-
tive tract, or drainage of  a pseudoaneurysm through the 
Wirsung duct. In severe cases of  acute pancreatitis, bleed-
ing may occur due to intra- or retroperitoneal erosion of  
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the vessels of  the celiac trunk, mainly the splenic artery. 
Diagnosis may be established by angiography or angio-
computed tomography. Angiography, besides identifying 
the bleeding point, sometimes allows embolization that 
may stop bleeding. If  this method fails, definitive treat-
ment must be surgery[92].
Ischemic complications (either local or related to 
remote vascular events) and venous or arterial compli-
cations - specifically splanchnic thrombosis and associ-
ated varices - are a major cause of  morbidity and mortal-
ity[93]. The reported frequency of  pulmonary embolism 
in acute pancreatitis is rare. The thrombohemorrhagic 
complications in pancreatitis play a tremendous part in 
developing its most severe forms and fatal outcomes. 
Early recognition and investigation of  thromboembo-
lism is imperative because accurate diagnosis and timely 
radiologic interventional procedures reduce mortality. 
Early treatment with intravenous heparin or thrombolysis 
is effective. Vascular filter insertion may be a life-saving 
measure for such patients[94].
Pseudoaneurysm
Pseudoaneurysm is a rare but potentially fatal complica-
tion of  acute pancreatitis. The risk of  rupture is as high 
as 37%[95]. The arteries involved include, in order of  
frequency, the splenic (40%), gastroduodenal (20%), pan-
creaticoduodenal (20%), gastric (5%), and hepatic (2%)[96]. 
The pathogenetic mechanism is secondary to degradation 
of  the vessel wall by pancreatic enzymes released from a 
destroyed pancreatic duct, resulting in a primary forma-
tion of  a pseudoaneurysm or rupture of  the vessel into a 
pre-existing pseudocyst, which then converts into a pseu-
doaneurysm. Pseudoaneurysms present symptoms such 
as gastrointestinal bleeding (60%), abdominal pain (50%), 
and splenomegaly or pulsatile abdominal tumors (5%), 
and spontaneous regression also have been reported[97,98].
Generally developing intracystically, they are usually 
diagnosed via angiography, which is used for locating and 
treating with embolization (with a high technical success 
rate of  93%-100%, and low 24 h and 30 d re-bleeding 
rates - 4% and 17%, respectively, Kalva et al[99]), but it 
should also be borne in mind when a pancreatitis patient 
is undergoing a CT scan. Gonzalez et al[100] have also dem-
onstrated that lipiodol with n-butyl cyano-acylate injected 
using endo-ultrasonography can be successful. If  these 
techniques are not successful or if  re-bleeding occurs, 
then surgery is required[25]. 
Necrotizing pancreatitis and pseudocysts involving 
the pancreatic tail appear to predispose patients to splen-
ic complications[101]. The incidence of  pseudocyst exten-
sion into the spleen has been estimated at around 1%. 
Erosion of  noncystic pancreatic inflammation occurs 
less commonly[102,103]. In a series of  500 patients with 
chronic pancreatitis, splenic complications were found 
in 11 patients (2.2%), four of  whom presented with 
splenic rupture. Five patients had intrasplenic pseudo-
cysts and 2 had intrasplenic subcapsular hematomas[104]. 
A series of  159 CT scans performed on 100 consecutive 
patients with acute pancreatitis found splenic infarcts in 
10 patients and subcapsular hemorrhage in 2 patients[105]. 
Another series of  238 patients with pancreatic pseudo-
cysts found 14 patients (5.9%) with splenic parenchymal 
involvement[106].
Management of  patients with subcapsular hematomas 
and/or splenic parenchymal pseudocysts is by conserva-
tive approach, percutaneous drainage, or surgery[106]. The 
hemodynamically unstable patient with splenic rupture 
or hemoperitoneum requires emergency laparotomy and 
either splenectomy or distal pancreatosplenectomy, which 
can reduce the risk of  pancreatic leak or fistula forma-
tion[104,106]. In hemodynamically stable patients, the deci-
sion for intervention should be based on clinical param-
eters rather than computed tomography imaging alone. 
A clinically stable patient with improving symptoms and 
resolving clinical signs can be managed conservatively 
with the intent of  splenic conservation. Follow-up is by 
serial ultrasound or computed tomography scans, which 
can show spontaneous regression. Time for resolution 
varies from 1 wk to 4 mo depending on the severity of  
the underlying pancreatitis[107].
Chylous ascites
Pancreatitis is a rare cause of  chylous ascites formation. 
It is believed that either lymph may actually leak through 
destroyed lymphatics because of  pancreatic enzyme ero-
sion or that chylous accumulation results from exudation 
of  chyle, caused by the obstruction of  lymphatic channel 
flow secondary to severe inflammatory changes that take 
place in the retroperitoneal space surrounding the pan-
creas[108]. Most cases involve chronic pancreatitis, though 
acute pancreatitis also has been recognized as the caus-
ative reason, with the first such report dating to 1984[109]. 
Since that time, only a few cases of  chylous ascites 
secondary to acute pancreatitis have been documented. 
In almost all, the presence of  chyle into the peritoneal 
cavity was discovered some time after the episode of  
pancreatitis, usually days or weeks[108]. However, Khan et 
al[110] reported a case of  acute hyperlipidemic pancreatitis 
(with normal serum amylase) that presented with acute 
chylous peritonitis and was treated conservatively. Smith 
et al[111] operated on a patient with relapsing pancreatitis 
and acute chylous ascites formation caused by a clinical 
resemblance with appendicitis.
Therapeutic choices may vary in accordance with the 
underlying pathology.
Thorough lavage of  the abdomen and adequate drain-
age is an excellent treatment modality for acute chylous 
peritonitis, because resolution of  chylous ascites usually 
occurs within the next few days. However, successful 
conservative treatment also has been reported[112]. Con-
servative treatment requires proper preoperative diagno-
sis, which is often difficult because of  the exceptional rar-
ity of  this condition and its resemblance to other surgical 
urgencies that call for immediate laparotomy. Long-term 
fasting, supported by total parenteral nutrition, frequently 
offers resolution. Alternatively, a high-protein low-fat diet 
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is effective at reducing the amount of  chyle produced. 
Administration of  octreotide is controversial[108].
In summary, the mortality rate for severe acute pan-
creatitis stands at between 15% and 30%, while if  the 
between 5% and 10% of  patients with parenchyma or 
peripancreatic necrosis are left untreated and it becomes 
infected, the mortality rate can be as high as 100%. The 
surgical methods and its timing are contentions regard-
ing treatment of  severe acute pancreatitis. Many studies 
showed that early surgery often was accompanied by 
higher mortality and morbidity rates. Faced with high 
morbidity and mortality rates of  operative necrosectomy, 
minimally invasive strategies are being explored by gastro-
intestinal surgeons, radiologists, and gastroenterologists. 
In cases where there are severe acute pancreatitis com-
plications, minimally invasive treatment is unsuccessful, 
or if  there is widespread necrosis in locations not easily 
reached using other techniques, then traditional open sur-
gery is strongly recommended. 
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